iVYLISA GIP Stool is a quantitative Sandwich ELISA designed to detect and quantify GIP (mainly those equivalent to the 33-mer peptide) in stool samples. The capturing and detecting antibody is the G12, which is designed against the 33-mer peptide and which recognizes it and other equivalent immunotoxic peptides18.
The iVYLISA GIP Stool kit from the iVYDAL In Vitro Diagnostics® line is a sandwich ELISA that detects and quantifies GIP in stool samples.
This kit is especially indicated for:
- Controlling gluten-free diets of CD patients, patients with gluten-sensitivity or a gluten allergy.
- Helping to correctly diagnose RCD.
- Controlling gluten-free diets for gluten-related disorders including eosinophilic esophagitis, lymphocytic duodenosis, iron deficiency anemia or type 1 diabetes, among other pathologies.
ELISA test for the detection of GIP in stool samples. This technique is for professional use and must be conducted in a clinical analysis laboratory or in a place approved for diagnostic tests.
Diagnostic sensitivity was calculated from the data from the performance evaluation study, Deliac-01-2012, in which 68 healthy subjects (i.e. they did not have gastrointestinal diseases) were analyzed. The gluten consumption of all patients was checked by means of dietary questionnaires.
Diagnostic sensitivity: 98.5%
After analyzing hundreds of food matrices, cross-reactivity has yet to be described. Diagnostic specificity was calculated by taking samples from 12 under one-year-old subjects who were exclusively formula-fed (thus ensuring a strict GFD). The samples were analyzed, obtaining negative results in all cases.
Diagnostic specificity: 100%.
Kit REF. Format iVYLISA GIP Stool KT-5739 96 wells